Mavaranegar – Evidence-Based Neuromodulation Leader in Iran & the Middle East
Mavaranegar, as the exclusive regional representative of MagVenture TMS in Iran and the Middle East, plays a strategic role in advancing evidence-based, non-invasive neuromodulation therapies across the region.
Our mission is centered on:
-
Technology transfer of advanced TMS systems
-
Standardized clinical training for healthcare professionals
-
Enhancing scientific knowledge in brain stimulation
With a strong commitment to clinical excellence, Mavaranegar continues to support the healthcare ecosystem by expanding safe, science-driven neuromodulation solutions aligned with international standards.
Specialized TMS Symposium at the Iranian Neurology Congress
In alignment with the 32nd Annual Neurology & Electrophysiology Congress of Iran, Mavaranegar hosted a specialized scientific symposium on neuromodulation.
This academic program highlighted:
✔ The latest clinical evidence in Transcranial Magnetic Stimulation (TMS)
✔ Advanced protocols in Peripheral Magnetic Stimulation (PMS)
✔ Therapeutic applications in neurological rehabilitation
The symposium was welcomed by neurologists, rehabilitation specialists, and neuroscience clinicians — establishing a collaborative platform for knowledge exchange and clinical innovation in brain-based therapeutics.
Visit of MagVenture’s Senior Regional Representative to Iran
During the congress, Mr. Matthias Kienle, Senior Representative of MagVenture, attended the event as an invited guest of Mavaranegar.
His visit included:
-
Participation in scientific programs
-
Technical and clinical discussions with Iranian specialists
-
Site visits to leading neuromodulation centers utilizing MagVenture devices
This collaboration reinforces regional scientific partnership, strengthens clinical standards, and supports the transfer of cutting-edge neuromodulation expertise into Iran’s healthcare system.
